Live interview with former NFL player Kendall Simmons, T1D

6:20 am PT, 9:20 am ET, 2:20 pm GMT

What time is this where you are?

Join us HERE at the time and date of this event.

Kendall Simmons is a former NFL® player who played nearly 10 years after being drafted by the Pittsburgh Steelers® as the 30th overall pick in 2002. Shortly before his second season began in 2003, Simmons was diagnosed with type 1 diabetes and was not sure if he would be able to continue his football career. With the help of team doctors and a strong support network, Simmons returned to the field that same year. As he learned to manage his diabetes, he regained his strength and flourished on the football field. In 2005, he started all 16 regular season games and all 4 playoff games with the Pittsburgh Steelers®, winning Super Bowl® XL over the Seattle Seahawks®. Today, Kendall has partnered with Novo Nordisk, a global health care company dedicated to diabetes care, to raise awareness of the importance of properly managing blood glucose levels and to demonstrate that diabetes can be successfully integrated into your life and ambitions. Kendall is participating in the 16th Annual Children with Diabetes Friends for Life Conference in Orlando to help show kids that diabetes doesn’t have to stand in the way of pursuing their dreams.


Join us for this event to meet Kendall real-time, hear his story and ask him questions!

Live interview with Dr. Michael Haller, TrialNet

12pm PT, 3pm ET, 8pm GMT

What time is this where you are?

Join us HERE at the time and date of this event.


TrialNet is an international clinical trials network of the world’s leading researchers who are exploring ways to prevent, delay and reverse progression of type 1 diabetes. The network consists of leading academic institutions, physicians, and research teams at the forefront of type 1 diabetes research.

TrialNet clinical studies explore new treatments toward delaying or preventing onset of type 1 diabetes in high risk individuals and protecting beta cells and remaining insulin production in those recently diagnosed. TrialNet also offers a unique screening test for relatives of people with type 1 diabetes to identify those at high risk for developing the disease.

TrialNet is jointly funded by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development and National Center for Research Resources at National Institutes of Health. It is also supported by the American Diabetes Association and JDRF.

Dr. Michael Haller

Dr. Michael Haller is a pediatric endocrinologist with a passion for patient care, teaching, and research. Dr. Haller’s research focuses on predicting, preventing, and reversing type 1 diabetes through a team approach that emphasizes translating findings from the laboratory bench to the patient’s bedside in a timely manner. Dr. Haller is an active investigator in the NIH funded Type 1 Diabetes TrialNet and The Environmental Determinants of Diabetes in Youth (TEDDY) study.

Dr. Haller currently serves as the Principal Investigator (PI) for the TrialNet ATG/GCSF study funded collaboratively by the NIH, the Helmsley Trust, and Sanofi. He also serves as a co-investigator for all other TrialNet studies at the University of Florida, and as the Chair of the Clinical Implementation Committee for the international TEDDY study.

Dr. Haller has also served as the PI of studies aimed at using autologous umbilical cord blood stem cells as a potential therapy for type 1 diabetes. Dr. Haller, in collaboration with Dr. Brusko continues to explore the potential for developing cord blood based therapies. Dr. Brusko is perfecting techniques that allow for the expansion of cord blood cells that help to regulate the immune system and Dr. Haller hopes to use these cells in future clinical trials.

In 2008, Dr. Haller, and his colleagues Dr. Desmond Schatz and Dr. Mark Atkinson received the JDRF’s highest award, the Mary Tyler Moore and S.Robert Levine Excellence in Clinical Research Award, for their team approach to developing therapies for type 1 diabetes. In 2009, Dr. Haller and his colleagues received the ADA Cure Award and in 2010 Dr. Haller received the ISPAD Young Investigator Award.

Live interview: Advances in glucagon with Locemia Solutions

1pm PT, 4pm ET, 8pm GMT

What time is this where you are?

Join us HERE at the time and date of the event

Locemia Solutions is a Canadian-based pharmaceutical development company, which sole focus is on innovating the rescue treatment of severe hypoglycemia. The team at Locemia is working on providing people with diabetes and those that touch their lives, with a simple, needle-free glucagon rescue product for the treatment of severe hypoglycemia, which would be easy to teach, easy to carry and easy to use – helping to expand the number of people who feel confident in dealing with the unpredictability of hypoglycemia, and providing peace of mind for people who use insulin every day. Locemia’s passion and promise – driven by its members personal involvement and investment in the diabetes community – is to fill an unmet need through innovation, awareness and empowerment—rooted in needle-free simplicity,  for everyone to be able to help anyone—quickly and easily— deal with severe low blood sugar.


Dr. Claude Piché
Co-Creator and CEO
Claude is leading the development of our solution. He has over 25 years of experience in developing and commercializing pharmaceuticals, vaccines, and diagnostics, including more than 12 years where he focused on diabetes therapeutics and hypoglycemia-related technologies. He has worked at large companies such as Merck, as well as start-up biopharmaceutical companies where he had roles in research, regulatory affairs, marketing, and operations.
Robert Oringer
Co-Creator and Chairman
Robert is passionate about reducing the burdens of dealing with diabetes. He has a long history of spreading the “be prepared” message as it relates to hypoglycemia and is a strong advocate for simplifying hypoglycemia rescue. He has over 25 years of experience as an entrepreneur, investor, and board leader in the diabetes field. Robert’s first diabetes company, CanAm Care, was built in the 1990s and created Dex4®, the leading brand of nonprescription hypoglycemia treatment products. Robert’s focus on bringing innovative ideas to diabetes stems from the experience of raising his two sons, both of whom have type 1 diabetes.

Live interview with Gary Scheiner, CDE

12pm PT, 3pm ET, 8pm GMT

What time is this where you are?

Join us HERE at the time and date of this event.

Bring your toughest diabetes questions!!  Gary is up for a challenge.

Gary is a certified diabetes educator, insulin-pump and continuous glucose monitor user and trainer, and Masters-level exercise physiologist.  He serves on the advisory boards of several diabetes device manufacturers and pharmaceutical companies; volunteers for the Juvenile Diabetes Research Foundation, Diabetes Exercise & Sports Association, American Diabetes Association, and Setebaid diabetes camps; and serves on the faculty of Children With Diabetes.  Gary teaches and art and science of blood-glucose balancing to people with diabetes throughout the world from his private practice, Integrated Diabetes Services as well as through his online school of higher learning for insulin users, Type 1 University.

Join us on the homepage of TuDiabetes for a live presentation and question-and-answer session with 
Gary Scheiner, founder of 
Integrated Diabetes Services and author of 
Think Like a Pancreas, 
The Ultimate Guide to Accurate Carb Counting, and now Until there is a Cure: the Latest and Greatest in Diabetes Self-Care.

This event is generously sponsored by BD Medical – Diabetes Care

Live interview with Scott Johnson, hosted by TuD member Rick Phillips

1pm PT, 4pm ET, 8pm GMT

What time is this where you are?

Join us HERE at the time and day of the event.

Scott is an experienced patient advocate. He works with a wide range of stakeholders across the healthcare environment to help them establish effective communication with the patient community. His expertise in the diabetes social media space is recognized worldwide and he advises organizations within the healthcare, food, and consumer goods industries.

Today he manages an award-winning blog “Scott’s Diabetes” that reaches more than 100,000 people annually, co-hosts a weekly radio show with over 30,000 annual listeners, is Communications Lead, USA for mySugr and Patient Pathways Lead at the Delta Project Management consultancy firm.

Scott is also a member of the Children with Diabetes faculty where he develops educational curriculums and content for the Friends for Life annual conference and regional events. He is on the Board of Directors for the Diabetes Hands Foundation, the Board of Directors for the Diabetes Community Advocacy Foundation, and is a founding member of Partnering for Diabetes Change, a coalition of people living with diabetes and industry representatives working to support underserved communities.

Live interview with Simon Carter, PredictBGL

1pm PT, 4pm ET, 9pm GMT

What time is this where you are?

Join us HERE at the time and date of the event.

Simon is the Founder of PredictBGL, a powerful mobile platform for safer diabetes.  PredictBGL was born from his own experience as a long-term Type 1 (1988), and as the parent of a Type 1 child (September 2007). He was led to create PredictBGL by his need to predict his daughter’s blood sugars overnight, his desire to monitor his daughter’s blood sugars while at school, and his (frugal Scottish ancestry coming to the fore) aim to have dose calculation and insulin on board tracking – without a pump.  The integrated prediction concept was recognised at Stanford’s DiabetesMine conference, and it was recently accepted into the 500 Startups pre-accelerator in San Francisco.

An outspoken diabetes thought leader and serial entrepreneur, Simon previously founded DataMystic, a data mining and data conversion software company. Simon is also CEO of DownloadPipe, a Tier 1 software download site.

Simon has an double degree with Honors in Electrical Engineering and Computer Science from Monash University.

PredictBGL is the only consumer diabetes management platform available where users can simply and easily log glucose, food, exercise and factors, calculate insulin (if required), and instantly see the effect on their future blood sugars. PredictBGL uses predictive analytics and visualization to deliver actionable data driven insights for dose changes, hypo predictions, delayed eating suggestions, meal sizes, food Glycaemic Indexes and more. It is the only app to predict blood sugars, the only app to include fat and protein in dose calculation, and the only app to share more than just blood sugars.

It is designed for people with Type 1, Type 2, Type 1.5, LADA, Gestational and  Pre-diabetes, and diabetes caregivers. The web portal gives access to Health Care Professionals.

PredictBGL is available for free download in the App Store shortly, in Google Play.

Live interview with Kim Overton, creator of SPIbelt

1pm PT, 4pm ET, 8pm GMT

What time is this where you are?

Join us HERE at the time and day of the event.


Our story is simple. Founder, Kim Overton, conceived the idea for SPIbelt™ on September 17, 2006 (easy to remember since it was the last day of Austin City Limits), while jogging with her key tucked into her bra top. Thinking, “there’s got to be a better way”, she went home that day and assembled the first sleek, no-bounce small personal item belt in red.

A few months and iterations of the belt later, Kim chose the name SPIbelt™ (Small Personal Item Belt), she filed the patents and trademarks and officially set up shop in her downtown apartment in Austin, TX, February 2007. A brand was born.

SPIbelt™ has been featured on The BIG IDEA with Donny Deutsch, CNN, The TODAY Show, The Rachel Ray show, Good Morning America and in a number of publications. Available in over 30 countries, SPIbelt™ has become the recognized brand people turn to when looking for a simple and secure means to carry their small personal items.

Since launch, the SPIbelt™ and our other uniquely innovative products have become staple accessories among runners, triathletes, travelers, individuals who carry medical devices such as an insulin pump (see SPIbelt for people with diabetes) or an EPIpen, and anyone on the go. Our goal is to continue to create products that help keep things in your life simple and safe.

Honored with the #175 spot on the Inc. 500 list of America’s Fastest Growing Companies in 2011, we credit our customers and team for our success. It is user stories, feedback, and photos that inspire our products’ function and design, and keep us moving forward.


Live TuDiabetes Update with Staff of Diabetes Hands Foundation

1pm PT, 4pm ET, 9pm GMT

What time is this where you are?

Join us HERE at the time and date of this event.

squarehandMelissa Lee, Interim Executive Director, is a long-time member and supporter of Diabetes Hands Foundation with her roots deeply planted in the community that she champions.

Diagnosed with type 1 diabetes at the age of 10, DKA and comatose with a blood sugar over 1000 mg/dL, Melissa spent her first 18 years with diabetes feeling alone with her disease. She discovered the TuDiabetes community in 2008 and enthusiastically dived in as one of the first two volunteer admins and later the first Lead Admin. She gives back to the community with her time, talent, and treasure because she credits it with finding the support she needed to get pregnant – twice – and better manage her diabetes on a daily basis. She has also served on the steering committee of Diabetes Advocates, another program of Diabetes Hand Foundation.


Mike Lawson, Head of Experience, is passionate about diabetes advocacy andmikehand since his type 1 diabetes diagnosis, has used social media to find and give emotional support to others that are living with diabetes. He has been a member of the TuDiabetes community since 2008, and brings with him over ten years of non-profit management and web development skills.

At The Diabetes Hands Foundation, Mike is responsible for the overall user experience and oversees the development of the visual identity and branding of the organization.


emilyhandEmily Coles, Head of Communities, was diagnosed with type I diabetes at the age of 3, and has spent her life working to understand, manage and thrive with this user-unfriendly disease.

She received a bachelor’s degree in biology in 1996, and then moved to the Bay Area and began working in public health.  In the following years she worked and volunteered for the AIDS Health Project, Iris Center women’s health outreach program, San Francisco Department of Public Health AIDS Office, and Stop AIDS Project.  In 2000 Emily returned to school, and the following year attained a Masters degree in Epidemiology from Stanford University.

In 2011, Emily joined Diabetes Hands Foundation as Program Manager to help develop and grow our many programs in both English and Spanish. She is now responsible for our online communities, TuDiabetes and EsTuDiabetes.